DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20161507

Analysis of prescribing pattern of antihypertensive drugs during pregnancy and neonatal outcome in a tertiary care centre

Soundarya Yamakanamardi, Anuradha HV, Sujani BK, Shivamurthy MC

Abstract


Background: Hypertensive disorders are the most common medical complications of pregnancy with an incidence of 2-8%. Maternal hypertension, even of the mild to moderate category, can lead to adverse perinatal outcomes like low birth weight, prematurity, stillbirth and intrauterine growth retardation. Though hypertension occurs up to 8% of pregnancies, yet information on the safety of antihypertensive medication use during pregnancy is limited. The objective of this study was to analyse the prescription pattern of antihypertensive drugs in pregnant woman and also to assess the neonatal outcome in pregnant woman on antihypertensive drugs.

Methods: The retrospective study includes analysis of all the prescriptions from case records of hypertensive pregnant women till the delivery for one year.

Results: Total number of 122 hypertensive pregnant patients was included in the study. Mean age of the patients was 25.8 years. 51.6% were primigravida. Most of them were diagnosed after 28±2 weeks of pregnancy. 54% were on monotherapy. Most commonly used drug was alpha methyl dopa followed by nifedipine. Out of 86.9% (n=106) live birth delivered; 29.2% were of low birth weight.

Conclusions: All the prescriptions were prescribed rationally. Most of the prescriptions contain monotherapy with alpha methyl dopa which is considered to be safest antihypertensives in pregnancy.


Keywords


Antihypertensive drugs, Pregnancy, Neonatal outcome, Retrospective study

Full Text:

PDF

References


Zibaeenezhad MJ, Ghodsi M, Arab P, Gholzom N. The prevalence of hypertensive disorders of pregnancy in Shiraz, Southern Iran. Iranian Cardiovascular Research Journal. 2010;4(4):169-72.

Report of the National high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynaecol. 2000;183:S1-S22.

Jabeen M, Yakoob MY, Imdad A, Bhutta AZ. Impact of interventions to prevent and manage preeclampsia and eclampsia on stillbirths. BMC Public Health. 2011;11(S6).

Hypertension in pregnancy (Report of the ACOG task force on hypertension in pregnancy). Obstetrics and Gynaecology. 2013;122(5).

Hooli TV, Santoshkumar J, Manjunath S, Vinodkumar CS. Drug utilization study of antihypertensives in obstetric practice in a tertiary care hospital. IJABPT. 2010;1(3):1006-10.

Caton AR, Bell EM, Druschel CM, Werler MM, Lin AE, Browne ML. Antihypertensive medication use during Pregnancy and the risk of cardiovascular malformation. Hypertension. 2009;54:63-70.

Sharma R, Khajuria R, Sharma P, Sadhotra P, Kapoor B, Kohli K, et al. Glaucoma therapy: prescribing pattern and cost analysis. JK Science. 2004;6(2):88-92.

JNC 7 express. The seventh report of the Joint National committee on prevention, detection, evaluation and treatment of high blood pressure. Available at http://www.nhlbi.nih.gov/guidelines/hypertension/express.pdf. Accessed 28 January 2016.

Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension 2008. Available at http://hyper.ahajournals.org/content/51/4/960.full.pdf+html. Accessed 04 February 2016.

Magee LA, Pels A, Helewa M, Rey E, Dedelszen PV. Diagnosis, evaluation and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can. 2014;36(5)416-34.

Pandya AS, Mistry VR, Chaudhari JS, Karelia BN, Shankar C, Hotchandani. Drug utilization study of antihypertensive drugs in pregnancy induced hypertension. Int J Res Med. 2013;2(2);26-9.